| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 41 | 31 | 19 | 21 | 35 | 58 | 47 | 46 | 52 | 92 | 115 | 117 | |
Growth YoY Revenue Growth YoY% | -42.7 | -66.0 | -63.3 | -63.9 | -13.1 | 88.9 | 148.0 | 115.1 | 48.9 | 59.2 | 146.2 | 152.8 |
| 47 | 35 | 21 | 28 | 35 | 54 | 44 | 46 | 53 | 87 | 86 | 112 | |
| -6 | -5 | -2 | -7 | 1 | 4 | 2 | 0 | -1 | 5 | 29 | 5 | |
OPM OPM% | -15.6 | -14.8 | -12.7 | -31.4 | 1.8 | 6.6 | 5.1 | 0.1 | -1.7 | 5.2 | 25.4 | 4.4 |
| 2 | 3 | 3 | 3 | 2 | -2 | 1 | 1 | 1 | 0 | 1 | 0 | |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Depreciation DepreciationCr | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 4 |
PBT PBTCr | -5 | -3 | 0 | -4 | 2 | 1 | 2 | 0 | -3 | 1 | 26 | 1 |
| -2 | -1 | 0 | 1 | -1 | 0 | 1 | 0 | 4 | -1 | 5 | 0 | |
| -4 | -1 | -1 | -5 | 2 | 1 | 2 | 0 | -7 | 2 | 21 | 0 | |
Growth YoY PAT Growth YoY% | -145.8 | -115.8 | -111.9 | -700.0 | 167.1 | 156.4 | 456.9 | 104.2 | -400.4 | 151.4 | 1,059.3 | 105.0 |
NPM NPM% | -8.6 | -4.0 | -2.7 | -22.1 | 6.7 | 1.2 | 3.9 | 0.4 | -13.5 | 1.9 | 18.3 | 0.3 |
| -0.8 | -0.3 | -0.1 | -1.0 | 0.5 | 0.1 | 0.4 | 0.0 | -1.3 | 0.3 | 3.9 | 0.1 |
| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 41 | 31 | 19 | 21 | 35 | 58 | 47 | 46 | 52 | 92 | 115 | 117 | |
Growth YoY Revenue Growth YoY% | -42.7 | -66.0 | -63.3 | -63.9 | -13.1 | 88.9 | 148.0 | 115.1 | 48.9 | 59.2 | 146.2 | 152.8 |
| 47 | 35 | 21 | 28 | 35 | 54 | 44 | 46 | 53 | 87 | 86 | 112 | |
| -6 | -5 | -2 | -7 | 1 | 4 | 2 | 0 | -1 | 5 | 29 | 5 | |
OPM OPM% | -15.6 | -14.8 | -12.7 | -31.4 | 1.8 | 6.6 | 5.1 | 0.1 | -1.7 | 5.2 | 25.4 | 4.4 |
| 2 | 3 | 3 | 3 | 2 | -2 | 1 | 1 | 1 | 0 | 1 | 0 | |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Depreciation DepreciationCr | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 4 |
PBT PBTCr | -5 | -3 | 0 | -4 | 2 | 1 | 2 | 0 | -3 | 1 | 26 | 1 |
| -2 | -1 | 0 | 1 | -1 | 0 | 1 | 0 | 4 | -1 | 5 | 0 | |
| -4 | -1 | -1 | -5 | 2 | 1 | 2 | 0 | -7 | 2 | 21 | 0 | |
Growth YoY PAT Growth YoY% | -145.8 | -115.8 | -111.9 | -700.0 | 167.1 | 156.4 | 456.9 | 104.2 | -400.4 | 151.4 | 1,059.3 | 105.0 |
NPM NPM% | -8.6 | -4.0 | -2.7 | -22.1 | 6.7 | 1.2 | 3.9 | 0.4 | -13.5 | 1.9 | 18.3 | 0.3 |
| -0.8 | -0.3 | -0.1 | -1.0 | 0.5 | 0.1 | 0.4 | 0.0 | -1.3 | 0.3 | 3.9 | 0.1 |
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|
Revenue RevenueCr | 334 | 182 | 133 | 237 | 377 |
Growth Revenue Growth% | -45.5 | -26.7 | 78.0 | 102.4 | |
| 299 | 190 | 138 | 231 | 338 | |
| 35 | -8 | -5 | 6 | 38 | |
OPM OPM% | 10.5 | -4.6 | -3.5 | 2.7 | 10.2 |
| 5 | 10 | 5 | 2 | 2 | |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 2 | 4 |
Depreciation DepreciationCr | 2 | 2 | 2 | 6 | 12 |
PBT PBTCr | 38 | -1 | -2 | 1 | 25 |
| 9 | -1 | 1 | 4 | 9 | |
PAT PATCr | 29 | 0 | -2 | -3 | 16 |
Growth PAT Growth% | -98.9 | -788.7 | -48.5 | 219.7 | |
NPM NPM% | 8.7 | 0.2 | -1.6 | -1.4 | 4.3 |
| 8.9 | 0.1 | -0.5 | -0.5 | 3.0 |
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|
Revenue RevenueCr | 334 | 182 | 133 | 237 | 377 |
Growth Revenue Growth% | -45.5 | -26.7 | 78.0 | 102.4 | |
| 299 | 190 | 138 | 231 | 338 | |
| 35 | -8 | -5 | 6 | 38 | |
OPM OPM% | 10.5 | -4.6 | -3.5 | 2.7 | 10.2 |
| 5 | 10 | 5 | 2 | 2 | |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 2 | 4 |
Depreciation DepreciationCr | 2 | 2 | 2 | 6 | 12 |
PBT PBTCr | 38 | -1 | -2 | 1 | 25 |
| 9 | -1 | 1 | 4 | 9 | |
PAT PATCr | 29 | 0 | -2 | -3 | 16 |
Growth PAT Growth% | -98.9 | -788.7 | -48.5 | 219.7 | |
NPM NPM% | 8.7 | 0.2 | -1.6 | -1.4 | 4.3 |
| 8.9 | 0.1 | -0.5 | -0.5 | 3.0 |
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 33 | 43 | 43 | 54 | 54 |
Reserves ReservesCr | 68 | 193 | 191 | 257 | 278 |
| 51 | 29 | 60 | 119 | 96 | |
| 62 | 77 | 107 | 34 | 26 | |
| 213 | 343 | 401 | 464 | 454 | |
| 151 | 226 | 193 | 228 | 219 | |
| 62 | 117 | 208 | 236 | 235 | |
| 213 | 343 | 401 | 464 | 454 |
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 33 | 43 | 43 | 54 | 54 |
Reserves ReservesCr | 68 | 193 | 191 | 257 | 278 |
| 51 | 29 | 60 | 119 | 96 | |
| 62 | 77 | 107 | 34 | 26 | |
| 213 | 343 | 401 | 464 | 454 | |
| 151 | 226 | 193 | 228 | 219 | |
| 62 | 117 | 208 | 236 | 235 | |
| 213 | 343 | 401 | 464 | 454 |
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 56 | 2 | 1 | -10 | |
| -55 | -144 | -53 | 7 | |
| -1 | 152 | 45 | 2 | |
Net Cash Flow Net Cash FlowCr | 0 | 10 | -7 | -1 |
Free Cash Flow Free Cash FlowCr | 18 | -44 | -112 | -45 |
CFO To PAT CFO To PAT% | 193.3 | 589.9 | -59.7 | 319.2 |
CFO To EBITDA CFO To EBITDA% | 159.7 | -22.4 | -28.1 | -163.3 |
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 56 | 2 | 1 | -10 | |
| -55 | -144 | -53 | 7 | |
| -1 | 152 | 45 | 2 | |
Net Cash Flow Net Cash FlowCr | 0 | 10 | -7 | -1 |
Free Cash Flow Free Cash FlowCr | 18 | -44 | -112 | -45 |
CFO To PAT CFO To PAT% | 193.3 | 589.9 | -59.7 | 319.2 |
CFO To EBITDA CFO To EBITDA% | 159.7 | -22.4 | -28.1 | -163.3 |
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 633 | 334 | 279 | 515 | |
Price To Earnings Price To Earnings | 2,080.0 | 31.7 | |||
Price To Sales Price To Sales | 3.5 | 2.5 | 1.2 | 1.4 | |
Price To Book Price To Book | 2.7 | 1.4 | 0.9 | 1.6 | |
EV To EBITDA EV To EBITDA | -71.7 | -81.1 | 49.8 | 14.3 | |
GPM GPM% | 13.5 | 0.0 | 5.7 | 10.6 | 10.6 |
OPM OPM% | 10.5 | -4.6 | -3.5 | 2.7 | 10.2 |
NPM NPM% | 8.7 | 0.2 | -1.6 | -1.4 | 4.3 |
ROCE ROCE% | 23.9 | -0.2 | -0.4 | 0.8 | 7.8 |
ROE ROE% | 28.9 | 0.1 | -0.9 | -1.1 | 4.9 |
ROA ROA% | 13.6 | 0.1 | -0.6 | -0.7 | 3.6 |
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 633 | 334 | 279 | 515 | |
Price To Earnings Price To Earnings | 2,080.0 | 31.7 | |||
Price To Sales Price To Sales | 3.5 | 2.5 | 1.2 | 1.4 | |
Price To Book Price To Book | 2.7 | 1.4 | 0.9 | 1.6 | |
EV To EBITDA EV To EBITDA | -71.7 | -81.1 | 49.8 | 14.3 | |
GPM GPM% | 13.5 | 0.0 | 5.7 | 10.6 | 10.6 |
OPM OPM% | 10.5 | -4.6 | -3.5 | 2.7 | 10.2 |
NPM NPM% | 8.7 | 0.2 | -1.6 | -1.4 | 4.3 |
ROCE ROCE% | 23.9 | -0.2 | -0.4 | 0.8 | 7.8 |
ROE ROE% | 28.9 | 0.1 | -0.9 | -1.1 | 4.9 |
ROA ROA% | 13.6 | 0.1 | -0.6 | -0.7 | 3.6 |
| Market CapitalizationMkt CapCr | 1,313 | 795 | 627 | 515 | 487 | 257 | 191 |
| Close PriceClose₹ | 446.15 | 79.28 | 179.37 | 94.91 | 1,610.80 | 58.67 | 9.81 |
| IndustryIndustry | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API |
| Price To EarningsPE | 25.02 | 16.62 | 11.13 | 31.74 | 37.59 | 6.78 | |
| Price To SalesPS | 2.56 | 1.02 | 0.93 | 1.37 | 1.46 | 0.65 | 109.52 |
| RevenueRevenueCr | 513 | 778 | 676 | 377 | 334 | 395 | 2 |
| Revenue Growth TTMRev Gr TTM% | -8.8% | 6.6% | 7.5% | 102.4% | -1.0% | -70.8% | |
| PAT Growth TTMPAT Gr TTM% | -55.3% | 23.4% | 4.8% | 219.7% | -44.7% | 81.7% |
| Market CapitalizationMkt CapCr | 1,313 | 795 | 627 | 515 | 487 | 257 | 191 |
| Close PriceClose₹ | 446.15 | 79.28 | 179.37 | 94.91 | 1,610.80 | 58.67 | 9.81 |
| IndustryIndustry | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API |
| Price To EarningsPE | 25.02 | 16.62 | 11.13 | 31.74 | 37.59 | 6.78 | |
| Price To SalesPS | 2.56 | 1.02 | 0.93 | 1.37 | 1.46 | 0.65 | 109.52 |
| RevenueRevenueCr | 513 | 778 | 676 | 377 | 334 | 395 | 2 |
| Revenue Growth TTMRev Gr TTM% | -8.8% | 6.6% | 7.5% | 102.4% | -1.0% | -70.8% | |
| PAT Growth TTMPAT Gr TTM% | -55.3% | 23.4% | 4.8% | 219.7% | -44.7% | 81.7% |